HomeXBRANE • STO
add
Xbrane Biopharma AB
Previous close
kr 5.78
Day range
kr 5.78 - kr 6.00
Year range
kr 5.62 - kr 38.25
Market cap
123.61M SEK
Avg Volume
61.49K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 9.09M | -86.19% |
Operating expense | 26.34M | -71.64% |
Net income | -26.48M | 50.22% |
Net profit margin | -291.41 | -260.48% |
Earnings per share | — | — |
EBITDA | -19.09M | 17.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 86.59M | -30.36% |
Total assets | 671.62M | -20.28% |
Total liabilities | 110.97M | -82.49% |
Total equity | 560.65M | — |
Shares outstanding | 20.61M | — |
Price to book | 0.21 | — |
Return on assets | -8.98% | — |
Return on capital | -10.22% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -26.48M | 50.22% |
Cash from operations | -67.56M | -171.94% |
Cash from investing | 4.76M | 127.54% |
Cash from financing | 57.43M | 242.73% |
Net change in cash | -10.65M | -111.36% |
Free cash flow | -52.46M | -141.83% |
About
CEO
Founded
2008
Website
Employees
29
